Presbia PLC (LENSF) Financial Statements (2025 and earlier)

Company Profile

Business Address SANDYFORD OFFICE CENTRE, SUITE 7
DUBLIN, 00000
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,428,0003,328,0001,052,0003,236,0007,060,00010,668,000
Cash and cash equivalent1,428,0003,328,0001,052,0003,236,0007,060,00010,668,000
Receivables12,00023,0008,0008,00011,00010,000
Inventory, net of allowances, customer advances and progress billings68,00071,00077,000127,000204,000249,000
Inventory68,00071,00077,000127,000204,000249,000
Other undisclosed current assets277,000305,000277,000108,000325,000492,000
Total current assets:1,785,0003,727,0001,414,0003,479,0007,600,00011,419,000
Noncurrent Assets
Property, plant and equipment388,000410,000448,000477,000613,000643,000
Intangible assets, net (including goodwill)1,378,0001,411,0001,444,0001,479,0001,495,0001,504,000
Intangible assets, net (excluding goodwill)1,378,0001,411,0001,444,0001,479,0001,495,0001,504,000
Other noncurrent assets89,00077,000128,000127,000128,000128,000
Total noncurrent assets:1,855,0001,898,0002,020,0002,083,0002,236,0002,275,000
TOTAL ASSETS:3,640,0005,625,0003,434,0005,562,0009,836,00013,694,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities738,000471,000761,000628,000473,000466,000
Accounts payable738,000471,000761,000628,000473,000466,000
Debt498,000482,000503,000480,000513,000522,000
Other liabilities364,000744,0001,079,0001,151,0001,523,0001,255,000
Due to related parties23,00035,00032,00023,00019,00028,000
Total current liabilities:1,623,0001,732,0002,375,0002,282,0002,528,0002,271,000
Noncurrent Liabilities
Long-term debt and lease obligation    459,000448,000
Long-term debt, excluding current maturities    459,000448,000
Liabilities, other than long-term debt115,000123,000131,000149,000138,000138,000
Deferred revenue and credits103,000107,000138,000138,000
Deferred rent credit92,00098,000 
Due to related parties    12,000  
Other liabilities23,00025,00028,00030,000  
Total noncurrent liabilities:115,000123,000131,000149,000597,000586,000
Total liabilities:1,738,0001,855,0002,506,0002,431,0003,125,0002,857,000
Equity
Equity, attributable to parent, including:1,902,0003,770,000928,0003,131,0006,711,00010,837,000
Common stock 17,00017,00017,00017,00017,00017,000
Additional paid in capital96,646,00096,266,00091,172,00091,362,00091,809,00091,195,000
Accumulated deficit(94,815,000)(92,567,000)(90,315,000)(88,302,000)(85,169,000)(80,429,000)
Other undisclosed equity, attributable to parent54,00054,00054,00054,00054,00054,000
Total equity:1,902,0003,770,000928,0003,131,0006,711,00010,837,000
TOTAL LIABILITIES AND EQUITY:3,640,0005,625,0003,434,0005,562,0009,836,00013,694,000

Income Statement (P&L) (USD)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
Revenues12,0003,0003,0001,0008,000 
Cost of revenue
(Cost of Product and Service Sold)
(2,000)(1,000)(47,000)(57,000)(12,000)(17,000)
Gross profit:10,0002,000(44,000)(56,000)(4,000)(17,000)
Operating expenses(2,464,000)(2,228,000)(1,923,000)(2,878,000)(4,710,000)(4,487,000)
Operating loss:(2,454,000)(2,226,000)(1,967,000)(2,934,000)(4,714,000)(4,504,000)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
 (10,000)    
Other undisclosed loss from continuing operations before equity method investments, income taxes    (38,000)  
Loss from continuing operations before equity method investments, income taxes:(2,454,000)(2,236,000)(1,967,000)(2,972,000)(4,714,000)(4,504,000)
Other undisclosed income (loss) from continuing operations before income taxes(11,000)(10,000)(9,000)24,000(6,000)(4,000)
Loss from continuing operations before income taxes:(2,465,000)(2,246,000)(1,976,000)(2,948,000)(4,720,000)(4,508,000)
Income tax expense (benefit)215,000(5,000)(37,000)(184,000)(20,000)(25,000)
Loss from continuing operations:(2,250,000)(2,251,000)(2,013,000)(3,132,000)(4,740,000)(4,533,000)
Loss before gain (loss) on sale of properties:(2,250,000)(2,251,000)(2,013,000)(3,132,000)(4,740,000)(4,533,000)
Net loss available to common stockholders, basic:(2,250,000)(2,251,000)(2,013,000)(3,132,000)(4,740,000)(4,533,000)
Other undisclosed net loss available to common stockholders, diluted      
Net loss available to common stockholders, diluted:(2,250,000)(2,251,000)(2,013,000)(3,132,000)(4,740,000)(4,533,000)

Comprehensive Income (USD)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
Net loss:(2,250,000)(2,251,000)(2,013,000)(3,132,000)(4,740,000)(4,533,000)
Comprehensive loss, net of tax, attributable to parent:(2,250,000)(2,251,000)(2,013,000)(3,132,000)(4,740,000)(4,533,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: